These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 9754836)

  • 21. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
    McNamara R; Kerans A; O'Neill B; Harkin A
    Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of stimulants and hallucinogens on shuttle avoidance in rats.
    Davis WM; Hatoum HT
    Gen Pharmacol; 1987; 18(2):123-8. PubMed ID: 3569841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Caffeine induces a profound and persistent tachycardia in response to MDMA ("Ecstasy") administration.
    McNamara R; Maginn M; Harkin A
    Eur J Pharmacol; 2007 Jan; 555(2-3):194-8. PubMed ID: 17126829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The threshold lowering effects of MDMA (ecstasy) on brain-stimulation reward.
    Hubner CB; Bird M; Rassnick S; Kornetsky C
    Psychopharmacology (Berl); 1988; 95(1):49-51. PubMed ID: 2898790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A behavioral comparison of Nexus, cathinone, BDB, and MDA.
    Bronson ME; Jiang W; DeRuiter J; Clark CR
    Pharmacol Biochem Behav; 1995; 51(2-3):473-5. PubMed ID: 7667371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the Psychedelic Amphetamine MDA (3,4-Methylenedioxyamphetamine) in Healthy Volunteers.
    Baggott MJ; Garrison KJ; Coyle JR; Galloway GP; Barnes AJ; Huestis MA; Mendelson JE
    J Psychoactive Drugs; 2019; 51(2):108-117. PubMed ID: 30967099
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening experiments of ecstasy street samples using near infrared spectroscopy.
    Sondermann N; Kovar KA
    Forensic Sci Int; 1999 Dec; 106(3):147-56. PubMed ID: 10680063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination.
    Hysek CM; Simmler LD; Schillinger N; Meyer N; Schmid Y; Donzelli M; Grouzmann E; Liechti ME
    Int J Neuropsychopharmacol; 2014 Mar; 17(3):371-81. PubMed ID: 24103254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adam and Eve make love. Analysis of the enantiomers of 3,4-methylenedioxy-N-ethylamphetamine (MDE, "Eve") and its metabolite 3,4-methylenedioxyamphetamine (MDA) in rat brain.
    Tucker G
    Hum Exp Toxicol; 1996 May; 15(5):455-7. PubMed ID: 8735473
    [No Abstract]   [Full Text] [Related]  

  • 30. Ecstasy analogues found in cacti.
    Bruhn JG; El-Seedi HR; Stephanson N; Beck O; Shulgin AT
    J Psychoactive Drugs; 2008 Jun; 40(2):219-22. PubMed ID: 18720674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study.
    Gouzoulis-Mayfrank E; Thelen B; Habermeyer E; Kunert HJ; Kovar KA; Lindenblatt H; Hermle L; Spitzer M; Sass H
    Psychopharmacology (Berl); 1999 Feb; 142(1):41-50. PubMed ID: 10102781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between activity and electronic state of hallucinogenic amphetamines.
    Kang S; Green JP
    Nature; 1970 May; 226(5246):645. PubMed ID: 5444928
    [No Abstract]   [Full Text] [Related]  

  • 33. Purity, adulteration and price of drugs bought on-line versus off-line in the Netherlands.
    van der Gouwe D; Brunt TM; van Laar M; van der Pol P
    Addiction; 2017 Apr; 112(4):640-648. PubMed ID: 27936283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hallucinogens, amphetamines and entactogens].
    Vollenweider FX; Vollenweider-Scherpenhuyzen MF
    Ther Umsch; 2003 Jun; 60(6):323-8. PubMed ID: 12848067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous use of alcohol with methamphetamine but not ecstasy linked with aggression among young adult stimulant users.
    Leslie EM; Smirnov A; Cherney A; Wells H; Legosz M; Kemp R; Najman JM
    Addict Behav; 2017 Jul; 70():27-34. PubMed ID: 28182965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MDMA: interactions with other psychoactive drugs.
    Mohamed WM; Ben Hamida S; Cassel JC; de Vasconcelos AP; Jones BC
    Pharmacol Biochem Behav; 2011 Oct; 99(4):759-74. PubMed ID: 21756931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes.
    Jones GM; Nock MK
    J Psychopharmacol; 2022 Jan; 36(1):57-65. PubMed ID: 34983261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the behavioral effects of mescaline analogs using the head twitch response in mice.
    Halberstadt AL; Chatha M; Chapman SJ; Brandt SD
    J Psychopharmacol; 2019 Mar; 33(3):406-414. PubMed ID: 30789291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling.
    Liechti M
    Swiss Med Wkly; 2015; 145():w14043. PubMed ID: 25588018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychedelic drugs: the ups and downs of ecstasy.
    Check E
    Nature; 2004 May; 429(6988):126-8. PubMed ID: 15141183
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.